0 Items
Select Page

Rotavirus

Rotavirus is a contagious virus that can cause gastroenteritis. Symptoms include severe, watery diarrhoea, vomiting, fever and abdominal pain. Infants and young children are most likely to contract rotavirus disease. Patients can become severely dehydrated, require hospitalisation and can even die.

The Native Antigen Company has developed a highly specific monoclonal antibody for research into Rotavirus infection.

Rotavirus Background

The genus rotavirus belongs to the Reoviridae family of viruses. Rotaviruses are non-enveloped, double-stranded RNA (dsRNA) viruses, capable of infecting animals, birds and humans. In the mature virion, a complex triple-layered viral capsid surrounds a genome, composed of eleven segments of dsRNA. These RNA segments code for 6 structural and 6 non-structural proteins (CDC). Rotavirus are classified according to the serological reactivity and genetic variability of the structural VP6 protein. Currently, eight species of rotavirus are recognised and are referred to as groups A-H. Group A rotaviruses are the most common cause of human disease, but group B and C rotaviruses have also been found to infect humans.

Rotavirus is transmitted from person-to-person by the faecal-oral route, via contact with faeces contaminated clothing, surfaces and infected individuals. Occasionally, the virus can be transmitted via respiratory droplets produced by coughing or sneezing. Rotavirus infection is the most common cause of severe diarrhoea in infants and young children worldwide. Symptoms of rotavirus infection include lethargy, fever, vomiting, abdominal pain, severe watery diarrhoea and dehydration. Severe dehydration can often lead to hospitalisation and in some cases death. Rotavirus infection in older children and adults may be mild or even asymptomatic.

Effective vaccines are available which have helped to reduce severe diarrhoea and childhood mortality caused by rotavirus infection. However, rotavirus continues to have a major global impact on childhood morbidity and mortality, particularly in developing countries (WHO).

References

  1. Centers for Disease Control and Prevention: Rotavirus
  2. World health organization: Rotavirus

Rotavirus Antibodies

Our monoclonal rotavirus antibody, clone R15, is specific to the VP6 structural protein of rotavirus. R15 does not cross-react with other organisms causing gastrointestinal infection, including Campylobacter spp., Clostridium difficile, Escherichia coli, Listeria monocytogenes, Salmonella spp., Shigella spp., Yersinia enterocolitica, Enterovirus, Norovirus, Astrovirus, Adenovirus, Cryptosporidium parvum, Giardia lamblia, Helicobacter pylori, Entamoeba histolytica, Staphylococcus aureus.

Questions?

Check out our FAQ section for answers to the most frequently asked questions about our website and company.

Diagnosing HIV in resource-limited settings

In this blog, we discuss the need for improved point-of-care (PoC) diagnostics for HIV and present the virus's cellular mechanism to illustrate our new range of HIV antigens and antibodies. HIV in the developed world On June 5th 1981 in Los Angeles, California, 5...

Our Product Pipeline

If you’ve been following us on social media recently, you might have noticed that we’ve been releasing a lot of new antigens and antibodies. In this blog, we explain how we use the WHO R&D Blueprint to guide our product development and present some highlights from...

From Outbreak to Epidemic: A Short History of The Ebola Virus

In the first of a two-part series, we discuss the history of the Ebola virus up to the ongoing outbreak in the Democratic Republic of Congo, and why this disease has been so challenging to fight. The 2014/15 epidemic In the summer of 2014, the world watched as the...

ELISA Formats for Infectious Disease Diagnostics

The field of diagnostics is rapidly developing, yet ELISA and PCR methods remain the most commonly used techniques in the diagnosis of bacterial and viral infections. In this blog, we discuss the advantages of using serological methods over molecular, PCR-based...

The world’s most extensive range of NS1-specific antibodies for flavivirus research

The Native Antigen Company first gained prominence in 2016, when it developed highly pure Zika virus NS1 protein during the 2015/2016 epidemic. Since then, the company has developed an extensive range of highly specific antigens, antibodies and immunoassays for...

Get in Touch

We sometimes send exclusive information and offers to our customers - please let us know if you are happy to receive these

3 + 15 =

Live Customer Feedback

Join our mailing list

* indicates required